Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2024
Published on: 28-Oct-2024 | SKU: HC_2024_1089

Need more details?
$4,950.00
DownloadLink
Need more details?

With an inclination toward patient-centric care delivery, the pharma industry follows a robust, step-by-step approach to market commercialization, with a clear understanding of the market stakeholders, segments, and post-launch forecasts to create seamless go-to-market strategies, develop a positive image, and instill confidence among healthcare providers using scientific data and testimonials. Pharma companies collaborate with third-party logistics providers and adopt adaptive supply chain strategies such as dual sourcing, stockpiling, and advanced scenario planning while tapping the capabilities of established distribution partners to avoid risks and disruptions.

Clearly defined marketing and sales strategies allow pharma companies to navigate regulatory bodies, end-user segments, and other technology vendors.

This Frost Radar™ includes companies that provide cutting-edge solutions and services across the commercialization value chain. The focus areas include supporting managed markets with respect to market access strategies, using AI/ ML-enabled platforms, and omnichannel marketing and sales strategies. Most profiled companies have a global presence.

Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.

Strategic Imperative

Strategic Imperative (continued)

Growth Environment

Growth Environment (continued)

Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2024

Frost Radar™ Competitive Environment

Frost Radar™ Competitive Environment (continued)

Frost Radar™ Competitive Environment (continued)

Frost Radar™ Competitive Environment (continued)

Aktana

Aktana (continued)

Aktana (continued)

Aktana (continued)

Axtria

Axtria (continued)

Axtria (continued)

EVERSANA

EVERSANA (continued)

EVERSANA (continued)

EVERSANA (continued)

iNIZIO

iNIZIO (continued)

iNIZIO (continued)

IQVIA

IQVIA (continued)

IQVIA (continued)

OPEN Health

OPEN Health (continued)

OPEN Health (continued)

OPEN Health (continued)

Syneos Health

Syneos Health (continued)

Syneos Health (continued)

Syneos Health (continued)

Syneos Health (continued)

Trinity Life Sciences

Trinity Life Sciences (continued)

Trinity Life Sciences (continued)

Trinity Life Sciences (continued)

Viseven

Viseven (continued)

Viseven (continued)

ZS Associates

ZS Associates (continued)

ZS Associates (continued)

Best Practices

Growth Opportunities

Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform

Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform (continued)

Significance of Being on the Frost Radar™

Frost Radar™ Empowers the CEO’s Growth Team

Frost Radar™ Empowers Investors

Frost Radar™ Empowers Customers

Frost Radar™ Empowers the Board of Directors

Next Steps

Legal Disclaimer

Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform

Growth Index

Growth Index (GI) is a measure of a company’s growth performance and track record, along with its ability to develop and execute a fully aligned growth strategy and vision; a robust growth pipeline system; and effective market, competitor, and end-user focused sales and marketing strategies.

  • Market Share (previous 3 years)
    This is a comparison of a company’s market share relative to its competitors in a given market space for the previous 3 years.
  • Revenue Growth (previous 3 years)
    This is a look at a company’s revenue growth rate for the previous 3 years in the market/industry/category that forms the context for the given Frost Radar™.
  • Growth Pipeline
    This is an evaluation of the strength and leverage of a company’s growth pipeline system to continuously capture, analyze, and prioritize its universe of growth opportunities.
  • Vision and Strategy
    This is an assessment of how well a company’s growth strategy is aligned with its vision. Are the investments that a company is making in new products and markets consistent with the stated vision?
  • Sales and Marketing
    This is a measure of the effectiveness of a company’s sales and marketing efforts in helping it drive demand and achieve its growth objectives.

Innovation Index

Innovation Index (II) is a measure of a company’s ability to develop products/ services/ solutions (with a clear understanding of disruptive Mega Trends) that are globally applicable, are able to evolve and expand to serve multiple markets and are aligned to customers’ changing needs.

  • INNOVATION SCALABILITY
    This determines whether an organization’s innovations are globally scalable and applicable in both developing and mature markets, and also in adjacent and non-adjacent industry verticals.
  • RESEARCH AND DEVELOPMENT
    This is a measure of the efficacy of a company’s R&D strategy, as determined by the size of its R&D investment and how it feeds the innovation pipeline.
  • PRODUCT PORTFOLIO
    This is a measure of a company’s product portfolio, focusing on the relative contribution of new products to its annual revenue.
  • MEGATRENDS LEVERAGE
    This is an assessment of a company’s proactive leverage of evolving, long-term opportunities and new business models, as the foundation of its innovation pipeline.
  • CUSTOMER ALIGNMENT
    This evaluates the applicability of a company’s products/services/solutions to current and potential customers, as well as how its innovation strategy is influenced by evolving customer needs.

Significance of Being on the Frost Radar™

Companies plotted on the Frost RadarTM are the leaders in the industry for growth, innovation, or both. They are instrumental in advancing the industry into the future.

  • GROWTH POTENTIAL
    Your organization has significant future growth potential, which makes it a Company to Action.
  • BEST PRACTICES
    Your organization is well positioned to shape Growth Pipeline™ best practices in your industry.
  • COMPETITIVE INTENSITY
    Your organization is one of the key drivers of competitive intensity in the growth environment.
  • CUSTOMER VALUE
    Your organization has demonstrated the ability to significantly enhance its customer value proposition.
  • PARTNER POTENTIAL
    Your organization is top of mind for customers, investors, value chain partners, and future talent as a significant value provider.

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

With an inclination toward patient-centric care delivery, the pharma industry follows a robust, step-by-step approach to market commercialization, with a clear understanding of the market stakeholders, segments, and post-launch forecasts to create seamless go-to-market strategies, develop a positive image, and instill confidence among healthcare providers using scientific data and testimonials. Pharma companies collaborate with third-party logistics providers and adopt adaptive supply chain strategies such as dual sourcing, stockpiling, and advanced scenario planning while tapping the capabilities of established distribution partners to avoid risks and disruptions. Clearly defined marketing and sales strategies allow pharma companies to navigate regulatory bodies, end-user segments, and other technology vendors. This Frost Radar includes companies that provide cutting-edge solutions and services across the commercialization value chain. The focus areas include supporting managed markets with respect to market access strategies, using AI/ ML-enabled platforms, and omnichannel marketing and sales strategies. Most profiled companies have a global presence. Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar . The publication presents competitive profiles of each company on the Frost Radar considering their strengths and the opportunities that best fit those strengths.
More Information
Deliverable Type Frost Radar
Author Aarti Siddhesh Chitale
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Pharmaceutical Commercialization
Keyword 2 Drug Marketing Solutions
Keyword 3 Pharma Service Innovations
Podcast No
WIP Number PFP2-01-00-00-00

Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2024

HealthcareFrost Radar™: Pharmaceutical Commercialization Solutions and Services, 2024

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

RELEASE DATE
28-Oct-2024
REGION
Global
Deliverable Type
Frost Radar
Research Code: PFP2-01-00-00-00
SKU: HC_2024_1089
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC_2024_1089